Clinical

Dataset Information

0

Testing ONC201 to Prevent Colorectal Cancer


ABSTRACT: This phase I trial tests the safety, side effects, and best dose of Akt/ERK Inhibitor ONC201 (ONC201) in preventing colorectal cancer in patients with familial adenomatous polyposis (FAP) or a history of multiple polyps. ONC201 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

DISEASE(S): Colorectal Carcinoma,Multiple Adenomatous Polyps,Adenomatous Polyps,Adenomatous Polyposis Coli,Colorectal Neoplasms,Familial Adenomatous Polyposis,Colorectal Adenomatous Polyp,Polyps

PROVIDER: 860 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2021-09-22 | GSE180160 | GEO
2023-08-07 | GSE189035 | GEO
| PRJNA432077 | ENA
| PRJNA432078 | ENA
| PRJNA561096 | ENA
2007-03-20 | GSE4107 | GEO
2016-06-01 | E-GEOD-79460 | biostudies-arrayexpress
| PRJNA432073 | ENA
2010-06-30 | E-GEOD-3898 | biostudies-arrayexpress
| 2006865 | ecrin-mdr-crc